ULTIMA GENOMICS OPENTRONS FLEX V2

The National Institutes of Health, through the Office of the Director and in alignment with the Department of Health and Human Services, is seeking to procure the ULTIMA GENOMICS OPENTRONS FLEX V2 system to support the NIH Intramural Sequencing Center’s high-throughput DNA sequencing operations. This acquisition is being conducted under Simplified Acquisition Procedures as prescribed by FAR subpart 13, specifically using the authority to solicit from a single source under FAR 13.106-1(b)(1), given the unique capabilities of the Ultima Genomics sequencer required for detecting underrepresented DNA sequences in mosaic samples. The contract will not exceed the simplified acquisition threshold of $350,000 and is not subject to full and open competition or FAR Part 6 requirements. The equipment will be delivered and installed at the NISC facility in Bethesda, Maryland, to enable deep sequencing applications critical for identifying low-abundance genetic variants with high accuracy. Interested vendors must submit a technical proposal, a cost-price proposal, and proposed period of performance by the deadline of June 27, 2026, at 9:00 a.m. Eastern Time, electronically to the designated point of contact. All respondents must have an active SAM registration, provide their Unique Entity ID and Taxpayer Identification Number, and certify their business size. The procurement is governed by the Federal Acquisition Circular 2005-99-1 dated July 16, 2018, and no set-aside provisions apply. No formal evaluation factors, inspection criteria, or packaging specifications are outlined in the presolicitation notice, as this is a non-competitive notice of intent to award a contract without soliciting competitive offers.